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Abstract
Background: The primary cause of cancer is gene mutation which allows the growth of abnormal and damaged
cells. Nutrition is one of the key factors that either increases or decreases the risk of cancer. Mannose has been
found in many fruits such as oranges, apples and berries. Mannose has been linked to increase the risk factors or
potential therapeutic for cancers. However, insufficient information is available on the effects of high mannose
concentration on the normal and cancer cell lines. This study aimed to evaluate the viability patterns of human
cancer and normal cell lines treated with mannose. Human gingival fibroblast (HGF), skin malignant melanoma
(A375) and colorectal adenocarcinoma (HT29) cell lines were cultured and treated with additional mannose in three
respective concentrations: 1 mg/ml, 5 mg/ml and 10 mg/ml. Then, cell viability was measured using an MTT (3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)-assay.
Results: The HGF cells’ percentage pattern of viability showed a rapid decline of nearly 95% on the third day of
treatment. A375 cells were able to survive in high mannose condition as the cell viability percentage was at the
highest value on Day 5. Meanwhile, HT29 cells showed declining cell viability pattern when treated with mannose.
The data exhibited significance; the p value was less than 0.001.
Conclusions: High mannose concentration can be toxic to HGF. In addition, A375 is adaptive to mannose at all
concentrations in which it shares the same pattern with the untreated group. However, the cell viability pattern for
HT29 cell is declining.
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Background
Cancer is a multifactorial disease that could be the result
from various factors including diet, lifestyle, environ-
ment, chemical and so forth [1]. However, the prime
aetiology of cancer is gene mutation as it would lead to
the production of abnormal or damaged cells. Physiolo-
gically, p53 is the tumour suppressor protein which plays
an important role in arresting or eliminating abnormal
and damaged cells [2]. Basically, the cell death would be
due to autophagy, apoptosis or necrosis. Autophagy is a
mechanism in which the cytoplasmic components are
engulfed in double-membraned vesicles before the lyso-
some degrades the vesicles [3]. Apoptosis is defined as
the process of cell shrinkage, DNA fragmentation and
phagocytosis by macrophages or neighbouring cells [4].
Meanwhile, necrosis is a mode of cell death that results
from the loss of integrity of the plasma membrane and
the breakdown of organelles with the release of proteo-
lytic enzymes which subsequently initiate the destruction
of the surrounding cells and promote the inflammation
[5]. In terms of cell death mechanism, apoptosis is better
than necrosis as it avoids the trauma towards the neigh-
bouring cells while necrosis increases the inflammation.
Chronic inflammation is one of the risk factors that
could lead to the formation of cancer [6]. Among cancer
survivors, food that could contribute to inflammation
need to be controlled.
Since a cancer survivor has the tendency to undergo
the recurrence of cancer, it is very essential to manage
the survivors of cancer in terms of dietary intake. Dietary
factors have been recognized to have significant effects
on increasing and decreasing the cancer risk [7]. The
needs and metabolic physiology of cancer survivors
might differ from normal people. A regimen of food
could possibly be designed to avoid the recurrence of
cancer among cancer survivors. For instance, one meta-
analysis study had summarized the adherence to a high-
quality diet and healthy dietary pattern is inversely asso-
ciated with the mortality of cancer survivors [8]. In order
to develop this regimen, it is necessary to conduct scien-
tific researches to understand the needs of either cancer
patients or the survivors. For instance, it is compulsory
to understand the behaviour and pattern of the cell lines
when they are treated with monosaccharides.
The focus of this study was to observe the cell viability
pattern of the normal and cancer cell lines when treated
with mannose. Mannose is a sugar monomer of the
aldohexose series of carbohydrates [9]. Commonly, man-
nose could be abundantly found in varieties of fruits
such as apples, oranges and berries [10]. Mannose has
been reported to play a vital role for the treatment of
congenital disorder of glycosylation (CDG) as the man-
nose improved the protein glycosylation [11]. In
addition, oral administration of mannose suppressed the
immunopathology in models of autoimmune diabetes
and airway inflammation [12]. However, high dosage of
mannose could cause injury towards the kidneys [13].
Furthermore, the scientific evidence on the cell viability
pattern of the normal and cancer cell lines that were
treated with mannose is insufficient. The findings of this
study will probably become a starting point to discover
more about cancer and sugar which would eventually
help the physician by suggesting the cancer patients to
avoid or reduce the intake of sugar derivatives that may
increase the risk factor of getting cancer. It is a fact that
our body needs sugar, but it is better to have options to
choose sugar that is less favourable by cancer cells. In
addition, the therapy for cancer could also be designed
in the future by incorporating the most favourable
monosaccharide with nanoparticles. Herein, this study
aimed to investigate the pattern of cell viability of nor-
mal and cancer cell lines when they are treated with
mannose for therapeutic value.
Methods
Selection and preparation of normal and cancer cell lines
The cell lines that were used in this study were normal
human gingival fibroblast (HGF-1, ATCC CRL-2014,
USA), human colorectal adenocarcinoma (HT-29, ATCC
HTB-38, USA) and human malignant melanoma (A375,
ATCC CRL-1619, USA). The cells were purchased from
American Type Culture Collection (ATCC) in which the
cells had undergone authentication and mycoplasma tests.
Media preparation, optimization of concentration and
treatment period
In this study, complete media was used for the cellular
growth. The complete media was formulated with Dul-
becco’s modified Eagle’s medium (DMEM) (Nacalai Tes-
que, Japan) added with 10% of foetal bovine serum (FBS)
(Himedia Laboratories Pvt Ltd, India) and 1% of anti-
biotic (streptomycin and penicillin) (Himedia Laborator-
ies Pvt Ltd., India). This complete media was used as the
control. Meanwhile, the treatment groups were prepared
by dissolving mannose in the complete media. The
optimization of concentration and treatment period for
in vitro stability studies was adapted and modified from
Shahbuddin [14]. Mannose was diluted properly at three
different concentrations which were 1 mg/ml, 5 mg/ml
and 10mg/ml. Then, the mixture of mannose and
complete media were sterilized by using the filter at
0.22 μm., Meanwhile, there were four different incuba-
tion periods (1, 3, 5 and 10 days) that were applied as a
treatment parameter to investigate the effect of mannose
on the cell viability of the tested cell lines.
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Culturing the cells for testing
The cells (HGF, A375 and HT29) were thawed and re-
vived in 25-ml culture flasks containing complete media
and incubated in CO2 incubator at 37
oC with 5% CO2.
The complete media were changed after 3 days of incu-
bation to ensure that the nutrients were sufficient for
cell growth and development. Once the cells had
achieved 80% of confluency, the cells were dissociated
for the cell viability test. The cell seeding was conducted
prior to the cell viability test. The cell was counted by
using haemocytometer with the ratio for the cells and
trypan blue of one to one. Approximately, 1000 cells
were aliquoted into 12-well plate as an initial seeding.
Then, the cells (HGF, A375 and HT29) were treated
with 1mg/ml, 5 mg/ml and 10mg/ml of mannose.
Meanwhile, the control group was treated with the
complete media which did not contain mannose. After
that, the treated cells were incubated at four incubation
periods (1, 3, 5 and 10 days). The fresh media of the con-
trol and treatment groups were changed every three days
of incubation to ensure the nutrient was sufficient. The
cell lines underwent the cell viability test once the incu-
bation period was completed.
Viability test by the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide) assay
MTT assay was conducted as a colourimetric technique
to assess the cell metabolic activity. The viable cell num-
ber is reflected from the mitochondrial activity through
the oxidoreduction reaction [15]. The treated cell lines
in the well plate were washed with phosphate buffer sa-
line (PBS) before the MTT reagent (Nacalai Tesque,
Japan) was added. Twenty microlitres of MTT reagent
with a concentration of 0.5 mg/ml was dispensed into
each well and incubated for at least 2 h. Subsequently,
after 2 h of incubation, the MTT reagent was aspirated
and 200 μl of dimethyl sulfoxide (DMSO) was added to
solubilize the formazan crystals. The absorbance was
measured with microplate spectrophotometer (Tecan
Trading AG, Switzerland) under a wavelength of 450
nm. All the cell viability processes were treated as a
light-sensitive process and wrapped with aluminium foil.
Data analysis
The Statistical Package for the Social Sciences (SPSS)
software version 22 was used to analyse the data ob-
tained from this study. The data were collected by tripli-
cating for each of the treatments at two independent
experiments. The treated groups with mannose were
compared with the control group. The values were
expressed as the standard error of the mean ± standard
deviation. The one-way ANOVA statistical test was con-
ducted in this study. p value ≤ 0.05 was considered
significant.
Results
This study was conducted to evaluate the role of man-
nose on the viability pattern, the cell lines (human gin-
gival fibroblast (HGF), skin malignant melanoma (A375)
and colorectal adenocarcinoma (HT29)) that were
treated with mannose at three different concentrations
(1 mg/ml, 5 mg/ml and 10mg/ml). The groups that were
treated with mannose were compared with the control
group (complete media). The graph portrays the cell via-
bility pattern of HGF cells that were treated with man-
nose at three different concentrations (Fig. 1). Overall,
the groups that were treated with mannose had caused
the cell viability pattern of the HGF cells to decline after
Fig. 1 The percentage of HGF cells when treated with mannose at 1 mg/ml, 5 mg/ml and 10 mg/ml for three period of times; day 1, day 3, day 5
and day 10 (p value < 0.001)
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day 1 at all concentrations (1 mg/ml, 5 mg/ml and 10
mg/ml). At day 3, the treatment groups (1 mg/ml and 5
mg/ml) declined dramatically from day 1. However, the
cell viability of these groups slightly increased at day 5
and continued to decline until day 10. Meanwhile, the
HGF cells that were treated with 10mg/ml mannose ex-
perienced rapid decline after day 1 until day 10.
The plotted graph depicts the cell viability pattern of
A375 cells which were treated with mannose with the
respective concentrations (Fig. 2). Based on the plotted
graph, the cell viability pattern of A375 cells shows the
potential to survive when treated with mannose. The
pattern of the cell viability of all groups that were treated
with mannose showed reduction after day 1. From day 3,
the cell viability was increasing until day 5 and then de-
creased on day 10. For the control group, after day 1,
the cell viability of A375 cells showed slightly declining
pattern which then continued to increase from day 3
until day 10.
The graph illustrates the cell viability of the HT29 cells
that were treated with mannose at three different con-
centrations (Fig. 3). In terms of cell viability pattern, all
groups that were treated with mannose distributed simi-
lar pattern which is a dramatic declining from day 1
until day 3. Then, the groups showed slight increment
from day 3 to day 5. Finally, the cell viability of the treat-
ment groups continued to decline until day 10. In con-
trast, the HT29 cells that were treated with complete
media (control group) showed a different pattern of cell
viability. The HT29 cells extremely increased from day 1
until day 5 of the incubation period. However, the cells
started to decline from day 5 until day 10.
Fig. 2 The percentage of A375 cells when treated with mannose at 1 mg/ml, 5 mg/ml and 10 mg/ml for three period of times; day 1, day 3, day
5 and day 10 (p value < 0.001)
Fig. 3 The percentage of HT29 cells when treated with mannose at 1 mg/ml, 5 mg/ml and 10 mg/ml for three period of times; day 1, day 3, day
5 and day 10 (p value < 0.001)
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The results of ANOVA are significant with the values
of all data were less than 0.05 which are considered as
significant (Table 1).
Discussion
The genetic changes that allow the growth of abnormal
cells would subsequently lead to cancer formation be-
cause of abundant of damaged cells in the body system.
From the findings, the cell viability of the normal cell
line that was treated with mannose at different concen-
trations continued to reduce from day 1 and onwards of
the incubation. Meanwhile, the cancer cell lines (A375
and HT29) that were treated with the mannose in vitro
showed the capability to adapt and survive. The genetic
between the normal and cancer cell lines play an import-
ant role for the metabolism of mannose.
Mannose’s toxicity is due to the shortage of mannose
phosphate isomerase which results in the accumulation of
mannose-6-phosphate [16]. The mannose-6-phosphate is
the result of the phosphorylation of mannose by gluco-
mannokinase [17]. In addition, mannose toxicity leads to
the depletion of adenosine triphosphate (ATP), a source
of energy [18]. Therefore, normal HGF cells could not
undergo the replication as the source of the energy is de-
pleted. In addition, by-products of the mannose metabol-
ism process such as reactive oxygen species (ROS) could
also potentially cause the cell death of normal HGF cells.
It has been reported that free radicals such as ROS could
induce oxidative stress, a condition that would subse-
quently lead to cell death [19].
Some studies have proven that mannose could help in
treating cancer. For instance, one study reported that
mannose causes growth retardation in some tumour
types in vitro, and intensifies the cell death in response
to major forms of chemotherapy [20]. In addition, man-
nose is beneficial in treating urinary tract infections [21].
The mannose binds to the E. coli which are then
discharged in the form of urine [22]. Chronic E. coli in-
fection might play a role in the development of bladder
cancer [23]. The infection causes the activation of nu-
clear factor kappa light chain enhancer of activated B
cells (NF-kB) pathway resulting in the inhibition of
apoptosis and increases the inflammation [24]. There-
fore, the survivability of the cancer cells would be due to
the activation of the NF-kB mechanism which blocks the
apoptosis pathway.
On the other hand, it has been reported that among
diabetic patients, mannose has the potential to enhance
diabetic complications as mannose glycated protein five
times better than glucose [10]. Glycation process would
lead to the production of advance glycation end prod-
ucts (AGEs). AGEs are collective name given to proteins,
lipids and nucleic acids that undergo irreversible modifi-
cation by reducing sugars or sugar-derived products
[25]. It has been reported that the AGEs and AGE recep-
tors interaction would stimulate the growth of human
pancreatic cancer via the autocrine induction-derived
growth factor-B [26]. Another study also reported that
AGEs triggered the growth and migration of culture hu-
man melanoma cells [27]. AGEs have been reported to
have the capability to mimic hormones or regulate their
receptors mechanism at DNA level [28]. Therefore, the
accumulation of these AGEs would interfere with nor-
mal physiological condition.
One of the limitations in this study is that only three
types of cell lines were used. It would be better if more
types of cancer and normal cell lines undergo the cell
viability testing in order to understand the effect of man-
nose on the cell lines. In addition, the metabolites that
were associated to cause cell death among the cell lines
were not tested. Therefore, in the future, a study to de-
tect the metabolites that enable the cell death or the
ability to survive would benefit in developing diagnostic
and therapeutic procedures for cancer.
Table 1 One-way ANOVA table
Sum of squares Df Mean square F p value
HGF–mannose
Between groups 0.005 15 < 0.001 8.308 < 0.001
Within groups 0.005 128 < 0.001
Total 0.011 143
A375–mannose
Between groups 67.000 15 4.467 50.277 < 0.001
Within groups 41.223 464 0.089
Total 108.223 479
HT29–mannose
Between groups 6.353 15 0.424 180.266 < 0.001
Within groups 1.062 452 0.002
Total 7.415 467
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Conclusions
In conclusion, high mannose concentration caused the
cell viability of normal human gingival fibroblast (HGF)
to rapidly decline since day 1 of treatment. The skin ma-
lignant melanoma (A375) and colorectal adenocarcin-
oma (HT29) have the potential to adapt to the high
mannose condition. Based on the cell viability pattern
showed by the A375 cell line, the cells displayed a simi-
lar pattern with the control group. Meanwhile, the cell
viability pattern of the HT29 cell line that was treated
with mannose showed a declining pattern. This could in-
dicate that mannose could possibly help in combating
the colorectal adenocarcinoma cell line. Therefore, the
findings of this study suggest that mannose has the po-
tential to be one of the alternatives of source energy
among colorectal adenocarcinoma cancer patients.
Nevertheless, further research still needs to be con-
ducted in order to evaluate the efficiency of mannose in
treating colorectal adenocarcinoma.
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